Related Experiment Video
Updated: Oct 9, 2026

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
Published on: May 26, 2023
Haemostatic changes in children with cyanotic and acyanotic congenital heart disease
1Department of Paediatrics, Maulana Azad Medical College and GB Pant Hospital, New Delhi.
Insights
Children with cyanotic congenital heart disease show more frequent coagulation abnormalities than acyanotic patients. These findings suggest subclinical disseminated intravascular coagulation and impaired clotting factor synthesis or platelet aggregation.
Area of Science:
- Pediatric Cardiology
- Hematology
- Coagulation Science
Background:
- Congenital heart disease (CHD) can affect hemostasis.
- Distinguishing coagulation profiles in cyanotic versus acyanotic CHD is crucial for patient management.
Purpose of the Study:
- To screen children with CHD for coagulation abnormalities.
- To compare coagulation systems in cyanotic and acyanotic CHD patient groups.
Main Methods:
- Comprehensive coagulation screening including CBC, PT, aPTT, fibrinogen, D-dimer, factors VII & VIII, and antithrombin III.
- Echocardiographically confirmed diagnosis in 25 cyanotic and 25 acyanotic children (<12 years) and age-matched controls.
- Analysis of red cell indices, bleeding time, and peripheral smear.
Main Results:
- Isolated laboratory abnormalities occurred with equal frequency (28%) in both acyanotic and cyanotic groups.
- Multiple coexisting coagulation abnormalities were significantly more common in cyanotic children (16/25 vs. 5/25).
- Thrombocytopenia and high hematocrit showed a significant association in cyanotic patients.
Conclusions:
- Laboratory hemostasis abnormalities are more prevalent in cyanotic CHD.
- Patterns suggest subclinical disseminated intravascular coagulation, reduced clotting factor synthesis, and/or platelet aggregation issues.
- These findings highlight the need for careful coagulation monitoring in pediatric CHD, especially cyanotic forms.
Abstract:
This study was undertaken to screen children with congenital heart disease for coagulation abnormalities and to compare the groups of cyanotic and acyanotic children with congenital heart disease with respect to abnormalities of the coagulation system. Following investigations were done in all the patients: complete blood count, erythrocyte sedimentation rate, peripheral smear examination, bleeding time, prothrombin time, activated partial thromboplastin time, assay of fibrinogen, D-dimer, factors VII and VIII and antithrombin III. Red cell indices were determined in 12 control, 12 acyanotic and 20 cyanotic children. Twenty-five patients each, with echocardiographically proven cyanotic and acyanotic congenital heart disease under 12 years of age constituted the study group; as many children of the same age group were included as the control group. The results showed isolated abnormalities of laboratory tests with equal frequency (28%) in acyanotic and cyanotic groups but coexisting abnormalities of more than one test were seen in significantly larger number of cyanotic children (5/25 and 16/25, respectively). A significant association was noted between thrombocytopenia and a high haematocrit in cyanotic patients. It is concluded that laboratory abnormalities of tests of haemostasis are more common in cyanotic congenital heart disease patients. The patterns of laboratory abnormalities suggest a chronic compensated disseminated intravascular coagulation at a subclinical level, reduced synthesis of clotting factors and/or deranged platelet aggregation in different subgroups of patients.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Mitral Stenosis I: Introduction

